Suppr超能文献

[作者是谁以及原因是什么?科学著作权会被修订吗?]

[Who is the author and why? Will the scientific authorship be revised?].

出版信息

Ned Tijdschr Geneeskd. 1998 Dec 19;142(51):2778-9.

Abstract

There is much ado about medical and scientific authorship. The criteria for authorship as stated by the International Committee of Medical Journal Editors are debated. For readers, reviewers and editors it is of importance to know who is accountable and responsible for the contents of published articles. For researchers and clinicians on the one hand and for funding bodies and faculty management on the other disclosure of the individual contributions of authors to a publication is important. Editors are willing to play the role of intermediary between these two parties. This discussion has not come to a conclusion yet, but some journals (Journal of the American Medical Association (JAMA), British Medical Journal (BMJ), The Lancet) have already begun to publish the contribution(s) of individual authors (as stated by the authors themselves) at the end of their articles. The editors of the Nederlands Tijdschrift voor Geneeskunde (Dutch Journal of Medicine) are also going to ask for the authors' contributions from January 1, 1999 and intend to publish them later on in the year in the same way as The Lancet does. The maximum number of 6 authors that is allowed now, may be lapsed since the contributions of all authors will be known.

摘要

医学和科学领域的作者身份问题引发了诸多讨论。国际医学期刊编辑委员会规定的作者身份标准备受争议。对于读者、审稿人和编辑而言,了解谁对已发表文章的内容负责至关重要。一方面,对于研究人员和临床医生来说,另一方面,对于资助机构和教师管理层而言,公开作者对出版物的个人贡献都很重要。编辑们愿意在这两方之间充当调解人的角色。这场讨论尚未得出结论,但一些期刊(《美国医学会杂志》(JAMA)、《英国医学杂志》(BMJ)、《柳叶刀》)已经开始在文章末尾公布每位作者的贡献(如作者自己所述)。《荷兰医学杂志》的编辑们也将从1999年1月1日起要求作者提供贡献说明,并打算在当年晚些时候以与《柳叶刀》相同的方式予以公布。由于所有作者的贡献都将为人所知,目前允许的最多6位作者的限制可能会失效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验